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The pathogenesis of rheumatoid arthritis (RA), similar to development of a majority
of inflammatory and autoimmune disorders, is largely due to an inappropriate or
inadequate immune response to environmental challenges. Among these challenges,
infectious agents are the undisputed leaders. Since the 1870s, an impressive list of
microorganisms suspected of provoking RA has formed, and the list is still growing.
Although a definite causative link between a specific infectious agent and the disease
has not been established, several arguments support such a possibility. First, in
the absence of a defined pathogen, the spectrum of triggering agents may include
polymicrobial communities or the cumulative effect of several bacterial/viral factors.
Second, the range of infectious episodes (i.e., clinical manifestations caused by
pathogens) may vary in the process of RA development from preclinical to late-stage
disease. Third, infectious agents might not trigger RA in all cases, but trigger it in
a certain subset of the cases, or the disease onset may arise from an unfortunate
combination of infections along with, for example, psychological stress and/or chronic
joint tissue microtrauma. Fourth, genetic differences may have a role in the disease
onset. In this review, two aspects of the problem of “microorganisms and RA” are
debated. First, is there an acquired immune deficiency and, in turn, susceptibility to
infections in RA patients due to the too frequent and too lengthy infections, which at
last break the tolerance of self antigens? Or, second, is there a congenital deficiency
in tolerance and inflammation control, which may occur even with ordinary infection
frequency and duration?
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INTRODUCTION
Rheumatoid arthritis (RA) pathogenesis, in the most general sense, is largely due to an inadequate
immune response in genetically predisposed individuals to environmental challenges, with bacteria
and viruses (latent carrier or clinical signs of infection) being the undisputed leaders among these
environmental challenges (Brooks et al., 2010; Le Dantec et al., 2015b).
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The microbial concept of RA triggering agents has been
discussed since the 1870s (Benedek, 2006). But, in spite of
this long history, a direct role of microorganisms in the
disease is controversial, while the suspected pathogen list is
still growing (Table 1). The fact is that it is impossible to
make a causal link between a specific pathogen and the disease.
In light of these disappointing results in understanding RA,
there are calls for even larger studies with the use of more
advanced technologies (Silman and Pearson, 2002; Carty et al.,
2004).
Several Explanations Can Be Proposed
for These Conflicting Results
First, in the absence of a defined pathogen, the spectrum
of microorganisms involved in triggering RA may include
polymicrobial communities or the cumulative effect of several
bacterial/viral factors. The simultaneous effects of various
pathogens on the immune system in an RA patient may have
different direct effects. It has been demonstrated that specific
infections (gastrointestinal and urogenital), hypothetically
associated with the changes in the gut microbiome, could
diminish or increase the risk of RA (Sandberg et al., 2015).
Second, the spectrum of bacteria and viruses, as well
as the reaction of the immune system to such pathogens,
TABLE 1 | Pathogens suspected of triggering rheumatoid arthritis (RA).
Bacteria and viruses Reference
Acanthamoeba polyphagamimivirus Shadidi et al., 2002
Acinetobacter spp. Carty et al., 2004
Alphavirus Leirisalo-Repo, 2005
Bordetella spp. Carty et al., 2004
Borrelia burgdorferi Imai et al., 2013
Campylobacter jejuni Shadidi et al., 2002
Candida albicans Hermann et al., 1991
Chlamydophila spp. Carter et al., 2010
Escherichia coli Newkirk et al., 2005
Flavivirus Li et al., 2013
Haemophilus spp. Carty et al., 2004
Helicobacterpylori Caselli et al., 1989
Herpesviridae Shadidi et al., 2002; Silman and
Pearson, 2002
Human Immunedeficiency Virus Carty et al., 2004
Leptospira interrogans pomona Sutliff et al., 1953
Mycobacterium tuberculosis Kim H.R. et al., 2006
Mycoplasma arthritidis Phillips, 1986
Mycoplasma fermentans Horowitz et al., 2000
Parvovirus Carty et al., 2004
Porphyromonas gingivalis Wu et al., 2010
Prevotella intermedia Martinez-Martinez et al., 2009
Proteus mirabilis Wilson et al., 2000
Rubivirus Hart and Marmion, 1977
Staphylococcus aureus Zahiri Yeganeh et al., 2015
Streptococcus pyogenes Phillips, 1986
Tannerella forsythensis Ogrendik, 2009
Yersinia enterocolitica Maslova et al., 2004
with or without clinical manifestations of infection, may
vary from preclinical to late-stage RA: such that any of
numerous pathogens may trigger RA at a preclinical stage,
but subsequently lose their influence in the advanced stage
(Arleevskaya et al., 2014). Moreover, the delicate balance between
pathogens and the anti-infection immune response of an RA
patient may be disturbed by several factors including the
limited mobility of the patients as well as the drug therapy
selected.
Third, infections might not trigger RA in all cases, but only in a
subset of the cases. For example, co-occurence with psychological
stress and/or chronic joint tissue microtrauma might be needed.
Indeed, in Swedish and Finish cohorts only 16–20% of the
patients reported infection in the early phase of RA (Leirisalo-
Repo, 2005); whereas in a Russian cohort this index was as high as
75% (Arleevskaya et al., 2014). The age at disease onset also seems
to be important since younger patients attributed their RA to a
previous infection more often than did older patients. (Soderlin
et al., 2011).
Fourth, the differences in trigger factors might reflect
variations in the pathogenetic mechanisms. Indeed, RA is
recognized as being a multigene disorder with a huge number of
genetic polymorphisms contributing to the disease pathogenesis.
The differences in trigger factors may also be due to geographic,
life style, drug or chemical exposures, and ethnic differences
(Konsta et al., 2015; Le Dantec et al., 2015a; Lemerle et al.,
2016). The diagnostic category of RA includes multiple subtypes
of the disease and the different phenotypes of RA might be
due to the different genotypes. In fact, the set of clinical signs,
which has been known since 1782 (Jonsson and Helgason,
1996), and which we call “RA” may be the outcome of
a variety of pathogenic pathways, or in other words, it
is a syndrome, i.e., a group of symptoms that arise as a
consequence of a number of different diseases (Weyand et al.,
1998).
Accordingly, two aspects of the problem of “pathogens and
RA” versus “RA and infections” are still debated. Is there an
acquired immune deficiency in RA patients caused by too
frequent and prolonged infections, which break tolerance of self-
antigens? Or, is there a congenital deficiency of the tolerance
and inflammation control, which may occur even with ordinary
infection frequency and duration?
ARGUMENTS FOR THE ACQUIRED
VERSUS INNATE HYPOTHESIS
The results of various studies testing the acquired or the
genetically determined predisposition to infections in RA are
rather contradictory. These differences can be explained by
several reasons. First, the conflicting results may be explained
in part by features of the patient groups studied, including the
particular therapeutic approach used and the specific types of
infections tracked by the authors (Vandenbroucke et al., 1987;
Widdifield et al., 2013; Sandberg et al., 2015).
Second, evolution of the immune system reaction to
pathogens during RA development is usually not taken into
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account. Our 10-year follow-up showed that both early stage
RA patients and their relatives suffer from more frequent
and prolonged minor infections than those individuals without
autoimmune diseases in their family history (Arleevskaya et al.,
2014). A gradual decrease in the frequency and duration of
the infectious episodes was observed in RA patients at a
later stage, when they were taken under observation at an
early stage and observed for longer than 3 years. It was also
observed from this cohort that the frequency and duration of the
infectious episodes increased even more in the year before the
RA onset, and that all the relatives who developed RA during
the observation (i.e., included in the study at the pre-clinical
stage) had a pronounced infectious syndrome (Arleevskaya et al.,
2014). It is noteworthy that Germano et al. (2014) reported an
association between the infection risk and disease activity, while
these authors also supported the hypothesis that the infectious
syndrome decrease with RA duration. With this in mind, we
speculate that there is probably both a congenital and or an
acquired deficiency of the anti-infection defense leading to the
frequent and prolonged minor infections in early RA patients
and their relatives. Attempts to eradicate the infections eventually
lead to a certain amount of success, but at the cost of RA
onset due to an inappropriate activation/inhibition of various
key parts of the immune system. It should be noted, that in
late stage RA, microbial colonization (including the increased
frequency of heavy Escherichia coli and Staphylococcus aureus
colonization) persists (Arleevskaya et al., 2014). So, in late
stage RA, despite the reduction of clinical signs of frequent
and prolonged infectious episodes, there are still laboratory
signs of dysbiosis. Thus, a delicate balance of microflora and
the immune host defense might be disrupted at any time, for
example, when there is a change in the therapy. This hypothesis
is indirectly confirmed by the data, indicating that a history
of previous infections appeared to be among the risk factors
for the infectious complications during infliximab and disease-
modifying anti-rheumatic drug therapy (Widdifield et al., 2013).
We interpret these data in such a way that, in RA patients
with a deficiency in their anti-infection defenses, which has been
manifested earlier in any infections and compensated for to
some extent later, the risk of renewal of infections still remains
high.
There are two possible approaches to the problem of
“infections and RA”. One of them, being of particular importance
for practicing rheumatologists, aims to study the susceptibility to
infections as a prognostic factor for the infectious complications
in RA therapy. The goal is to study all patients without exception,
including those with a variety of reasons for the development
of infection complications, even in the absence of RA (such
as leucopenia, low mobility, diabetes, or other comorbiditiesl;
Doran et al., 2002; Soderlin et al., 2011). The results of these
studies indicate an increased susceptibility to infections in RA
patients. The second approach is to study the role of infections
in the provocation and persistence of RA activity. In this case, it
seems logical (albeit with obvious damage to the completeness of
coverage of the problem) not to extend the study on the patients
with the concomitant additional risk factors for the infection
development.
THE ACQUIRED HYPOTHESIS
There is a definite list of possible mechanisms by which
the pathogen/host interactions could trigger pathological
autoimmune responses: molecular mimicry, epitope spreading,
polyclonal lymphocyte activation, bystander activation, and
viral persistence (Bach, 2005; Kivity et al., 2009; Vojdani, 2014;
Floreani et al., 2015).
Molecular Mimicry
Molecular mimicry occurs when foreign antigens bear sufficient
structural similarity to self-antigens (i.e., similar epitopes). As
a result, an immune response to pathogens could lead to cross
reactivity with self-antigens. The similarity of pathogen and self-
antigen structures is a widespread phenomenon. By exact peptide
matching analysis, it was demonstrated that all human proteins
harbor a bacterial penta- or hexa-peptide motif (Trost et al.,
2010). Moreover, the study of pathogenic and non-pathogenic
proteomes from Vibrio cholera and Mycobacterium tuberculosis
up to Lactobacillus acidophilus and Bifidobacterium adolescentis
showed that the bacterial pathogenicity does not affect the cross-
reactivity with human proteins. So, molecular mimicry would
seem to be too commonplace to shift on it the blame for the
development of autoimmune diseases. In the inflammatory foci
a variety of bacterial proteins undergo several different types of
post-translational modifications, and most of these proteins have
motifs similar to those found in human polypeptides.
Epitope Spreading
Epitope spreading is a phenomenon in which the immune T or
B cell response extends beyond the original epitope. In general,
epitope spreading is quite a beneficial phenomenon, contributing
to the ability of the immune system to attack multiple pathogens
(Powell and Black, 2001). Epitope spreading develops in the
process of an ongoing immune reaction during an acute or
persistent infection and following tissue destruction. Epitope
spreading optimizes protection against newly encountered
pathogens and assists in clearing inflammatory sites of damaged
endogenous proteins of the body’s own tissues. Its success is
due to the ability to quickly target new epitopes and the ability
to adequately destroy pathogens and clear inflammatory sites.
It appears evident that, due to RA development, abnormalities
occur in the mechanisms that would otherwise constrain epitope
spreading only to the diversity of foreign antigens and prevent
development of an immune response to self-epitopes. A complete
review of these abnormalities and self-epitopes is beyond the
scope of the present discussion. We’ll briefly examine only some
aspects. Epitope spreading can result from a change in a protein
structure. One well-known example, protein citrullination, which
is a conversion of arginine to citrulline by peptidyl arginine
deaminase (PAD), could be due to development of an immune
reaction against the original protein or its citrullinated form, but
may also arise against other citrullinated proteins.
Currently interest in the well-established link between
periodontitis and RA (Helminen-Pakkala, 1968) is going
through a renaissance. This reignited interest is due to
clarification of the role of citrullinated peptides as epitopes
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with pathogenic significance in RA, and identification of the
ability of Porphyromonas gingivalis, the main pathogen in chronic
periodontitis, to citrullinate proteins by using its own PAD
(Maresz et al., 2013). Thus, this situation represents a clear
example of an autoimmune disease triggered by infection via
molecular mimicry and epitope spreading mechanisms. When
activated, B lymphocytes initially producing antibodies (Ab)
against the citrullinated P. gingivalis enolase, start producing
Ab against citrullinated human enolase, and then against other
citrullinated endogenous proteins (reviewed in Lundberg et al.,
2010). Quirke et al. (2015) compared the incidence in RA
patients of increased levels of serum Ab to arginine containing
proteins (enolase, vimentin, fibrinogen), and to the citrullinated
modifications according to the occurrence of lung bacterial
infections. As compared to RA control patients, lung infections
were associated with an elevated level of Ab to citrullinated
proteins.
Polyclonal Lymphocyte Cctivation
Microbial molecules can directly induce proliferation and
differentiation of T- and B-lymphocytes regardless of their
antigen specificity. In the model of murine Trypanosoma
cruzi infection, it was shown that the number of high rate
immunoglobulin secreting cells of both IgM and IgG classes
increased up to 100 fold each and a variety of effector T cell
activities were revealed, with both Ab and cellular immune
reactions being predominantly non-specific (Arala-Chaves et al.,
1992). Similar observations have been recorded in various viral,
bacterial and fungal infections. The authors provided the results
of their experiments, showing that as much as 95% of Ab
produced in response to an infectious stimulus fail to bind
to the antigens used for the immunization. The polyclonal
activation normally produced excessive amounts of usually low-
affinity Abs, which are directed against foreign and self-antigens.
With regards to expression of the anti-immunoglobulin G Abs
(also known as rheumatoid factor, RF) in human RF-positive
Tg murine models, results differed according to the timing of
the infection. On the one hand and following acute influenza
viral infection, an abortive activation of RF-positive B cells and
no increase in RF production characterized infected mice as
compared to the uninfected ones (Woods et al., 2007); while,
on the other hand, the same group also reported that chronic
bacterial infection in the RF-positive Tg mice was associated
with increased RF production, which resulted from polyclonal
lymphocyte activation (Soulas et al., 2005).
In RA, peripheral blood and synovial lymphocyte polyclonal
activation is well documented, although its extent is limited
since hypergammaglobulinemia does not occur in these patients
(Becker et al., 1990; Bucht et al., 1992; Yamamoto et al., 1992;
Outschoorn et al., 1993; Brown et al., 1995). When testing the
serum levels of Ab free light chains (as a biomarker of B cell
activation) in a large cohort of the general population, Deng
et al. (2015) reported elevated levels of the polyclonal free light
chains 3–5 years before clinical onset of RA, an elevated level that
remains during the follow-up of the patients. The authors pointed
out that the elevation was moderate, and failed to demonstrate
any correlation with mortality in the RA group.
A number of the results demonstrate that the situation with
the polyclonal lymphocyte activation in RA is complicated. The
data of recent studies, which tested the isotype distribution,
antigen specifity and affinity of the serum and synovial fluid RFs
and anti-CCP Abs as well as the expression of the inherently
autoreactive idiotope 9G4 in preclinical, early and advanced
stages of RA, failed to clarify whether such a process is crucial
in RA development (Moyes et al., 1996; Verpoort et al., 2006,
Ioan-Facsinay et al., 2008; Cambridge et al., 2014, Falkenburg
et al., 2015). When analyzing these data, it looks like the anti-
citrullinated Abs are produced due to the ongoing immune
response to citrullinated proteins, while RFs appear later and
persist due to both the polyclonal and antigen-driven activation
of B lymphocytes (Renaudineau et al., 2005). Cambridge et al.
(2014), speculated that “in RA, autoreactive B cell specificities
escape deletion, receptor editing or anergy early in their
development, ultimately giving rise to a population of B cells
which can also survive entry into the mature B cell compartment
in the periphery.”
Another important aspect is the imperfection of the polyclonal
activation of peripheral blood B-lymphocytes from RA patients.
The cell response to bacterial peptidoglycan, pokeweed mitogen,
or phorbol myristate acetate stimulation was significantly
reduced compared to controls (Abrahamsen et al., 1978; Pardo
et al., 1984). Synovial fluid lymphocytes also proliferated poorly
when stimulated polyclonally (Abrahamsen et al., 1978; Petersen,
1988). Finally, RA lymphocytes stimulated by the polyclonal B
cell activator Epstein-Barr virus (EBV), produced less IgM than
controls after 1 week and showed increasing IgM production
between 14 and 21 days, whereas, in normal lymphocytes, IgM
production decreased during this period (Irving et al., 1985).
Bystander Activation
Autoreactive cells may be expanded and activated by non-
specific means or by a combination of non-specific effects with
self antigens being released and presented in an inflammatory
environment created by infection (Kim B. et al., 2006). Most
studies examining non-cognate T cell responses have focused
on CD8 T cells, primarily in viral infection models with the
stimuli being the products of infected cells, or inflammatory
molecules generated by chronically virus-infected tissues or
the factors produced by the cells, activated during the viral
molecules interaction with toll-like receptors (Miller et al., 1997;
Horwitz et al., 1998; Toubi and Shoenfeld, 2004; O’Donnell
and McSorley, 2014). However, bacteria, in particular the intra-
macrophage bacteria, also may be responsible for the bystander
activation (Das et al., 2000; McSorley, 2014; O’Donnell and
McSorley, 2014). One of the main factors provoking bystander
activation is related to proinflammatory cytokines. At least in
experiments studying this phenomenon, the proinflammatory
cytokine cocktails or any of these cytokines are typically used
for the cell stimulation (Unutmaz et al., 1994; Brennan et al.,
2008). Cytokine stimulation of naive and resting memory T
cells results in the proliferation of the lymphocytes and display
of the effector functions of the memory T cells as measured
by lymphokine synthesis and help stimulate immunoglobulin
production by B cells (Unutmaz et al., 1994). At the same time,
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T cells activated by cytokines in the absence of T cell receptor
stimulation also activate monocytes and monocyte cytokine
production (Sebbag et al., 1997). Evidently these processes
occur in RA pathogenesis (Sebbag et al., 1997; Brennan et al.,
2008).
THE INNATE HYPOTHESIS
Human Leukocyte Antigens (HLA)
Recent results from genome wide association studies (GWAS)
support a contributory role of genetic and epigenetic factors in
the development of RA (Konsta et al., 2015). The most well-
studied genetic example is related to the RA associated DRB1∗01
and ∗04 alleles (shared epitopes), which are effective, when
expressed, in binding citrullinated peptides, and presenting them
to T cell receptors which is the optimal scenario for development
of an immune response against citrullinated peptides, as well as
for activation of the proinflammatory Th1 cytokine production
(Tian et al., 1998; Rosloniec et al., 2002b; Auger and Roudier,
2005; Gourraud et al., 2006; Ohnishi et al., 2006). Moreover in
RA patients, an increased expression of the HLA-DR molecules
has been reported leading to a significant low-affinity peptide
presentation and activation of autoreactive peripheral T cells
(Kerlan-Candon et al., 2001; Rosloniec et al., 2002a; Hill et al.,
2003; Auger and Roudier, 2005; Gourraud et al., 2006, 2007;
Ohnishi et al., 2006).
With regards to associations between infections and HLA-
DR peculiarities in RA, HLA-DRB1∗0404 was associated with a
low frequency of occurence of T cells specific for EBV gp110,
a replicative phase glycoprotein which is critical for the EBV
infection control (Toussirot et al., 1999). While opposite to
this, HLA-DRB1∗07, an allele associated with reduced risk of
developing RA, was associated with the highest frequencies of
the peripheral blood T-lymphocytes specific for gp110. Therefore,
it’s not surprising that EBV DNA and EBV-encoded RNA I
transcripts are present significantly more often in synovial tissue
of patients positive for the shared epitope (especially HLA-
DRB1∗0404–positive; Saal et al., 1999). When considering HLA-
DRB1 alleles predisposing to the development of recurrent herpes
lymphocytic meningitis and CMV reactivation, results were more
contrasted with the characterization of both RA-associated non
share epitopes HLA-DRB1∗09 and DRB1∗15, and RA-associated
share epitopes HLA-DRB1∗01/∗04 (Du et al., 2007; Kekik et al.,
2009; Kallio-Laine et al., 2010; Acar et al., 2014).
Non-HLA Genes
Other gene polymorphisms associated with RA development
are mainly related to imperfect control of lymphocyte activity
(PTPN22, CTLA-4, BTLA, and others) (Plenge, 2009; Oki et al.,
2011). Due to these SNPs the immune response becomes difficult
to manage (Figure 1). The impaired clearance of inflammatory
sites caused by an imbalance of the pro-oxidant and anti-oxidant
factors and inadequate activity of several enzymes involved in
remodeling of the extracellular matrix may also be affected by
mutations in the genes of the corresponding factors (Mattey et al.,
1999, 2000; Nemec et al., 2006; Ling et al., 2007).
NF-κB and Jak/STAT Pathway
For all the diversity of RA-associated gene SNPs, an enrichment
of these RA-associated genes was found in particular in two
pathways: the NF-κB and the JAK-STAT signaling cascades
(Diogo et al., 2014; Messemaker et al., 2015).
The NF-κB pathway (Figure 2) is considered to be a
prototypical proinflammatory signaling pathway controlling
both RA pathogenesis and viral infection, due to the expression
of proinflammatory genes of chemokines, cytokines, receptors,
apoptotic regulators, intracellular signaling molecules, and
transcription factors (Hinz et al., 2002; Lawrence, 2009). Indeed,
stimulation of the NF-κB signaling pathway and inhibition
of TNF-related apoptosis (impaired in RA even without this
additional exposure) potentiate RA development. Such a pathway
could be amplified in the case of infections with CMV and
EBV, since the viruses need live, functional and activated
“lymphocytes” which could be achieved by controlling the same
NF-κB signaling pathway and, in turn, by blocking TNF-related
apoptosis (Goodkin et al., 2003).
STATs are a family of proteins which are latent transcription
factors activated by extracellular signaling ligands such as
cytokines, growth factors and hormones (Abroun et al., 2015).
The principal RA players: IL6, TNF-α as well as IFNs, exert
their biological functions through the JAK/STAT signaling
pathway (Figure 2), proteins which are being overexpressed
in the various cells in RA (Rottapel, 2001; Shouda et al.,
2001). STAT proteins become activated in the cytoplasm by
Janus kinases (JAK), a family of tyrosine kinases. These
signaling pathways have diverse biological functions, which
include participating in inflammation and cell differentiation,
proliferation, development and apoptosis. In particular, TNF-α
production and NF-κB pathway activation can occur through
JAK/STAT signaling (Ahmad et al., 2015). At the same time
NF-κB positively regulates STAT5a expression and signaling




Herpes Simplex Virus Type 1 and 2
(HSV1/2) Prevalence and Ability to
Escape the Immune System Response
Worldwide rates of either HSV-1 or HSV-2 in adults are found
to be 60–95% (Chayavichitsilp et al., 2009), and due to such
a high level of exposure, some authors have suggested that
these viruses should be considered to be part of the normal
microbiotic flora (Grinde, 2013). However, diagnosis of an HSV
infection based on the presence of viral DNA in blood cells
does not provide comprehensive information since HSVs can
take up life-time residency in nerve cells during the latency
phase and are transported to the mucosa during reactivation
phases (Grinde, 2013). The latency versus reactivation strategy
of the Herpesviridae is defined by the balance between viral
proliferation and the ability of the immune system to clear the
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FIGURE 1 | In case of infection, the cellular and molecular players of rheumatoid arthritis (RA) are affected. Infections are able to promote citrullinisation
(1) and antigen presentation (2) through HLA-DR overexpression in antigen presenting cells (APC); to interfere with T helper (Th) polarization (3) and cytokine
production (4); to reduce lymphocytotoxic activity (5) as well as antibody production (6) and antigen presentation by B cells (7). Abbreviations: Mono, Monocyte;
Mp – macrophage; TCR, T cell receptor; PAD4, peptidyl arginine deaminase 4; ACPA, anti-citrullinated protein antibodies; IL, interleukine; IFNγ, interferon gamma;
TNFα, tumor necrosis factor alpha; IC, immune complex; RF, rheumatoid factor.
virus (Grinde, 2013). During the latent state, the viral genome
is packaged by histones and copied by the host cell’s DNA
polymerases, along with the chromosomes, primarily when the
cell engages in mitosis (Knipe and Cliffe, 2008; Grinde, 2013).
This contrasts with lytic replication in which the viral DNA
polymerase is engaged, reflecting a viral takeover of the cell.
Reactivation may be provoked by various factors, leading to
activation of demethylation and histone modification processes,
processes that appear to be excessive in RA (Bottini and Firestein,
2013; Wada et al., 2014, de Andres et al., 2015). As a whole,
the virus’s tactics to avoid immune detection and establish
latency works in a significant population – up to 80% in human
adults for HSV-1 and about 40% for HSV2 (Akhtar and Shukla,
2009).
According to our data the ratio of people with clinical signs
of HSV exacerbation (criteria reviewed in Grinde, 2013) is
significantly increased in the early stage of RA as well as among
the first degree relatives of these patients (Arleevskaya et al.,
2014). However, when considering HSV1/2 DNA detection in
blood, joint tissues and synovial fluid cells, an infrequent presence
of HSV1/2 infection has been reported in the patients with early
diseases (Zhang et al., 1993; Stahl et al., 2000). In late stage RA, the
prevalence of the serum IgG anti-HSV antibodies and the viral
DNA presence in the blood and synovial fluid cells were similar to
that seen in controls (Us et al., 2011). The data on the serum IgM
anti-HSV antibody prevalence in RA are contradictory and could
not help resolve the discordance observed between the biology
and clinical observations (Kurbanov and Mamedov, 2009; Us
et al., 2011).
Cellular Sensitivity and Response to
Herpes Infection in RA
Since spreading of the virus from cell to cell depends on
specific receptors, the presence of these receptors plays a critical
role in viral infection and, in turn, in disease exacerbation
(Akhtar and Shukla, 2009). Among them, the herpes virus entry
mediator (HVEM), a member of the tumor necrosis factor
receptor superfamily, serves as one of the entry receptors of
HSV (Gavrieli et al., 2006; Cai and Freeman, 2009). In RA,
HVEM is overexpressed and contributes to the proliferation
and activation of synovial fibroblasts (Ishida et al., 2008). This
factor is overexpressed on most cell types found in RA synovial
tissues (Kang et al., 2007; Shang et al., 2012). Serum levels of
soluble HVEM are increased in RA as well (Jung et al., 2003). So,
HVEM overexpression in RA is suspected of contributing to HSV
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FIGURE 2 | Activation of the NF-κB and JAK-STAT signaling pathways are crucial for proper antiviral response. However, in case of infection,
bacteria/viruses have a number of opportunities to inhibit both pathways: trigger NF-κB translocation from cytoplasm into the nuclei (1) through plasma membrane
(2, bacteria) or endosomal (3, viruses) TLR activation; by activing various STAT family members that being important for the virus replication (4), by controlling STAT
activation/translocation to the nucleus (5); and last but not least by reducing the activity of the suppressor of cytokine signaling-3 (SOCS3), a host negative regulator
of the JAK/STAT pathway (6). Abbreviations: TLR, Toll like receptor; TIR, Toll/IL-1R; MyD88, myeloid differentiation primary response gene 88; NF-κB, nuclear factor
kappa B; IkB – inhibitor of the NF-κB kinase; P – phosphate residue (activated form); Cytokine R, a cytokine receptor with β1 and β2 subunits; JAK, Janus tyrosine
kinase familly; STAT, signal transducer and activator of transcription family; SOCS3, suppressor of cytokine signaling 3.
dissemination and to the RA progression directly or indirectly via
reception of the viruses.
The epidermal growth factor receptor (EGFR) is another
receptor by which HSV enters a cell. EGFR is found to
be overexpressed on a variety of synovial tissue cells, and
the receptor gene overexpression in bone marrow-derived
mononuclear cells is due to an RA-associated SNP (Nakano et al.,
2005; Nakamura et al., 2006; Lo et al., 2012; Yuan et al., 2013; Xu
et al., 2015).
Immune Surveillance of the
Herpesviridae Infection in RA
The capacity of the immune system to effectively control
Herpesviridae is determined by the adequacy of the virus (i) to
directly interact with the immune system through the pattern
recognition receptors (PPR), (ii) to modulate cytokine and
chemokine production, and (iii) to control invariant natural
killers (iNK) T cells, CD8+ cytotoxic T cells (IFN-γ, TNF-
α, cytolytic molecules including perforin and granzymes), and
the ability of the immune system to establish and maintain a
pool of HSV-specific memory/effector CD8(+) T-lymphocytes
(Figure 3).
Pattern Recognition Receptors
The viruses are recognized by PPR, among which the mannose
receptors are considered to be the most important (Summerfield
et al., 1995; Seppanen et al., 2009). Some preliminary evidence
suggests that mannose receptors may be overexpressed on
immune cells of myeloid lineage present in blood and synovial
tissue from RA patients (Put et al., 2013).
One member of the secreted soluble PPR family, the mannose-
binding lectin (MBL), is a complement component and an
opsonic factor binding to HSV. Serum MBL levels vary according
to the history of the disease. In early RA, low MBL levels were
revealed, which are associated with a higher risk of developing
early erosive RA and higher levels of IgM RF and CRP (Jacobsen
et al., 2001; Saevarsdottir et al., 2001), and later, the MBL levels
are increased (Saevarsdottir et al., 2007). Given the likely increase
of MBL expression during RA evolution from early to late stage,
the data by Olsen et al are of interest, showing that in the early
stage of RA, the MBL gene is down regulated more than threefold
compared with late stage RA (Olsen et al., 2004). The importance
of MBL in RA physiopathology is reinforced by the observation
of a nucleotide polymorphism (SNP) at MBL gene associated RA
susceptibility (Ip et al., 2000; Jacobsen et al., 2001), and with HSV
infection reccurences, possibly due to impaired recognition of the
viruses (Seppanen et al., 2009).
Cytokines and Chemokines
The initial stages of Herpesviridae infection are predominantly
influenced by the activity of iNK cells to produce type I
interferons (IFN), which limit the spread of viruses. The other
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FIGURE 3 | Dangerous liaisons between infections and RA. In case of viral infections such as observed with Herpesviridae, the immune system limits viral
infection by producing proinflammatory cytokines (e.g., interferon, IFN), anti-viral antibodies and through the activation of cytotoxic cells such as CD8+ T cells and
innate natural killer cells (iNK). In case of RA, a defective antiviral activity is observed together with factors promoting Herpesviridae propagation (e.g., herpes virus
entry mediator, HVEM, and epidermal growth factor receptor, EGFR, overexpression; downregulation of the opsonic factor MBL, mannose binding lectin). At the
opposite, infections promote autoimmunity by inducing protein citrulinisation, by promoting HLA-DR overexpression, and by interfering with the pathways involved in
the production of cytokines and chemokines, Jak/STAT and NF-κB (see Figure 2).
inhibitors of the infection are macrophages (producing IFNs,
TNF-α, and IL-6), and lymphocytes that are instrumental in
active immune surveillance by producing IFN-γ (Khanna et al.,
2003; Khanna et al., 2004; Egan et al., 2013). Activated CD4+
and CD8+ T cells play a pivotal role in clearing the primary
infection (Nash, 2000; Egan et al., 2013). After resolution of
the primary infection, a small proportion of the primed specific
T cell population generates a stable long-term memory cell
pool, which activates during reactivation of a latent infection
(Crough et al., 2005). Both nonspecific and specific CD8+ T
cells infiltrate and persist within virus infected cells, the specific
CD8+ T-lymphocytes being the prevailing ones, expressing a late
effector memory phenotype and being activated by stimulation
from the infected cells (Borysiewicz et al., 1988; Posavad et al.,
2000; van Lint et al., 2005; Verjans et al., 2007; Zhu et al.,
2007). It appears that the principal role of B cells in the immune
response to Herpesviridae infection is not to produce neutralizing
antibodies but instead to present antigens and secrete cytokines
(Deshpande et al., 2000; Youinou et al., 2005, 2009; Gazeau et al.,
2015).
While the IFN-γ levels were increased in the synovial fluid of
early and late stage RA patients, the serum levels of the cytokines
were close to that seen in controls (Bucht et al., 1996). Some
authors also pointed out that, although IFN-γ was revealed in
the synovial fluid and membrane, IFN-γ T cell producers were
absent from peripheral blood and locally present in the joint
tissues in small quantities (Ridderstad et al., 1991; De Keyser
et al., 1995). T-helper 1 (Th1) cells rather than the antiviral
CD8+ cytotoxic T-lymphocyte subset represent the main cellular
source of IFN-γ in RA (Schuerwegh et al., 1999). Moreover,
experiments using killed influenza virus (Berg et al., 2000), EBV
lytic/latent peptide epitopes (Klatt et al., 2005) also support a
defective capacity of the immune system to produce IFN-γ in
response to viral stimulation. As a consequence, it has been
proposed that a low serum level of IFN-γ may be an important
factor for recurrence and reactivation of the virus (Minami
et al., 2002; Davis et al., 2013; Deng et al., 2015; Motamedifar
et al., 2015). A link between cytokine production and HLA
alleles associated with an increased risk of RA development,
HLA DRB1∗0401 and DQ8, has been also established (Taneja,
2015).
At the molecular level, Herpesviridae produce proteins
that are effective to control various STAT family members
and the translocation of NF-κB from the cytoplasm into
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the nuclei, which is necessary for (re)activation of the virus
(Tsavachidou et al., 2001; Goodkin et al., 2003; Kuchipudi, 2015).
As an example, STAT1 regulates the expression of the HSV-
1 latency-associated transcript by interacting with its promoter
(Kriesel et al., 2004). However, the STAT family proteins also
regulate gene expression of a number of antiviral factors. This
was elegantly demonstrated in a STAT3-deficient mouse model
infected with HSV-1 that produced less IFN-γ and virus-specific
CD8+ T cells (Yu et al., 2013). Another consequence of an
infection by HSV-1 is its capacity to produce the suppressor
of cytokine signaling-3 (SOCS3), a host negative regulator of
the JAK/STAT pathway, which, in turn, inhibits the IFN-γ
capacity to induce phosphorylation of JAK kinases (Yokota
et al., 2004). As a whole, Herpesviridae have the opportunity
to inhibit proinflammatory cytokine production (Melroe et al.,
2004; Cox et al., 2015) through the control of the T cell response
(Toussirot et al., 1999; Toussirot et al., 2000; Klatt et al., 2005).
Such effect contributes to the reactivation of the Herpesviridae
infection.
Another gene that is remarkably down regulated in early RA is
the CC chemokine receptor 1 (CCR1), which regulates leukocyte
migration to infection sites. Inhibition of this factor in herpes-
infected mice caused a decreased and shortened recruitment of
natural killer cells and led to an impaired antiviral response
with a significantly higher viral level, inspite of the markedly
enhanced levels of pro-inflammatory cytokines (Sorensen and
Paludan, 2004). It is noteworthy that Olsen et al. (2004)
concluded that, in total, the early RA signature showed some
overlap with that seen in the normal immune response to viral
antigens.
Inate Natural Killers and Cytotoxic CD8 T
Cells
The iNK subset is a minor population of the innate-like
T-lymphocytes. They serve as an early source of cytokines
(Opasawatchai and Matangkasombut, 2015). When stimulated
by the altered glycolipids of the infected host cells, iNKT
rapidly begin to release a variety of cytokines and chemokines,
including IFNs and TNF-α, and exert direct cytolysis (Chang
et al., 2007; Matsuda et al., 2008; Tessmer et al., 2009;
Horst et al., 2012). An adequate response of these cells is
required for control of the viral load and protection from
the massive tissue damage that can occure in cases of severe
viral infection (Grubor-Bauk et al., 2003; Grubor-Bauk et al.,
2008). The iNK cells have specific value in keeping the virus in
latency.
Several studies have unambiguously reported qualitative and
quantitative abnormalities in the iNKT population in early stage
RA. Mansour et al. (2015) showed that, in early stage RA,
circulating iNKTs were reduced and their frequency was inversely
correlated with the disease activity score. The proliferative iNKT
response was also defective. Functional iNKT alterations were
due to a skewed iNKT-TCR repertoire with a selective reduction
of high-affinity clones. Furthermore, the high-affinity iNKTs
exhibited an altered functional Th profile with Th1 (in treatment-
naive) or Th2-like (in treated patients) phenotype, compared
to Th0-like Th profiles exhibited by high-affinity iNKTs in
controls. Cell cytotoxicity of iNK in early stage RA is also
reduced (Taylor et al., 1993). It is noteworthy that in late stage
RA the data, obtained by various authors were controversial:
the number of the iNK and their functions were found to be
increased, decreased, or didn’t differ from that seen in controls
(McChesney and Bankhurst, 1986; Taylor et al., 1993; Aggarwal
et al., 2014).
The population of the virus specific CD8+ T-lymphocytes and
their cytotoxic activity focused on infected cells or the separate
Herpesviridae peptide epitopes is decreased both in the early
and late stage RA in contrast to an abundant and hyperactivated
whole population of CD8+ T cells of various specificities (Moss
et al., 1983; Gaston et al., 1986; Toussirot et al., 2000; Shimojima
et al., 2008; Carvalheiro et al., 2015).
CONCLUSION
Obviously, the ideal immune system response to bacterial/viral
aggression should be based on the principles of a reasonable
adequacy and a perfect balance between all parts of the immune
system. However, for some patients such a delicate equilibrium
could be broken, leading to the development of RA. Several
factors are suspected for this including:
1. A susceptibility to bacterial and viral infections greater than in
the general population;
2. An imbalance of the immune system greater than in the
general population;
3. An incapacity to control the inflammatory reactions, and this
becomes one of the major factors provoking RA development;
4. Last but not least, disharmony in the relationship of
microorganisms and the immune system of an individual
predisposed to developing RA, which may be due to both
genetic and epigenetic problems.
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